Coherus Oncology (CHRS) Tax Rate Growth (1y) (2020)

Coherus Oncology (CHRS) Tax Rate Growth (1y) (2020) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	65,839.48 Bn	65,839.20 Bn	-
2	Nanobiotix	1,912.79 Bn	1,912.72 Bn	-
3	Akari Therapeutics	1,015.37 Bn	1,015.37 Bn	-
4	BeOne Medicines	471.39 Bn	466.59 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.52 Bn	115.28 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.33 Bn	61.58 Bn	3.31 Bn
7	Belite Bio	62.74 Bn	62.74 Bn	-
8	Argenx Se	56.10 Bn	50.91 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.52 Bn	34.51 Bn	959.66 Mn
10	Coherus Oncology	198.46 Mn	31.41 Mn	8.50 Mn

Download Data